ClinicalTrials.gg
RecruitingNCT07549555Updated Apr 24, 2026

Effect of Manual Chest Wall Vibration on Respiratory Function and Chest Tube Duration After Thoracic Surgery

An interventional study of Chest Wall Oscillation and Conventional Control in Thoracic Diseases, sponsored by Saglik Bilimleri Universitesi. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-24.

Sponsored by Saglik Bilimleri Universitesi · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Apr 2026, 7 months ago, but the record still lists the study as recruiting.
  • Registered 6 months after the study started (first participant enrolled Oct 2025, registered Apr 2026).
  • Started Oct 2025; still recruiting 1 year 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study was conducted to determine the effects of a manual vibration technique applied to the chest wall on the duration of chest tube placement, secretion clearance, and hemodynamic parameters in patients with chest tubes.

Read the detailed description

This study was conducted to determine the effects of a manual vibration technique applied to the chest wall on the duration of chest tube placement, secretion clearance, and hemodynamic parameters in patients with chest tubes.

Thoracic surgery is a method used in the treatment of diseases of the lungs, pleura, chest wall, and mediastinum. The primary problems encountered by patients postoperatively include improper patient positioning, incision pain, ineffective coughing, reduced lung volume, postoperative pulmonary complications, inadequate airway clearance, frozen shoulder on the side of the thoracotomy, postural abnormalities, and persistent chest wall tension. These issues, particularly pulmonary complications, can delay patient recovery, prolong hospital stays, and increase morbidity and mortality. Tube thoracostomy is a one-way drainage system that facilitates the drainage of fluid and air from the pleural space, maintains negative pressure, and allows for lung expansion. Additionally, it allows for the administration of therapeutic medications into the pleural space. Patients should be educated on respiratory exercises-such as coughing, balloon inflation, and the use of a triflowmeter-to facilitate lung expansion and secretion clearance, and they should be encouraged to perform these exercises regularly. A review of the literature reveals no studies investigating the effectiveness of manual vibration in patients with chest tubes. It is believed that this technique may shorten the duration of chest tube placement. Additionally, due to the lack of cost-effectiveness of mechanical vibration, supply issues, the inability to use it effectively on all patients in clinical settings, the recommendation for more frequent use, and the necessity of applying it based on the patient's needs rather than at regular intervals (such as every two hours)-a determination that must be made by the nurse closely monitoring the patient- it is anticipated that the manual vibration technique will provide greater benefits at regular intervals without incurring additional costs, as it adapts to the patient's needs and the clinic's operational schedule throughout the day.

02

Conditions studied

  • Thoracic Diseases

Browse trials for

Keywords

  • Thoracic surgery
  • Chest tubes
  • Chest wall oscillation
  • Physical therapy modalities
  • Postoperative care
  • Airway Clearance Techniques
03

In context

Thoracic Diseases

72 studies on the registry are indexed under Thoracic Diseases; 13 are open to participants now.

This study's planned enrollment of 60 is close to the median of 65 across 52 interventional studies indexed under Thoracic Diseases.

Browse Thoracic Diseases studies →

Lead sponsor

Saglik Bilimleri Universitesi is the lead sponsor of 453 studies on the registry; 140 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Having undergone thoracic surgery
  • Having a chest tube in the postoperative period
  • Being hemodynamically stable
  • Agreeing to participate in the study
  • Being open to communication and cooperation

Exclusion criteria

Exclusion Criteria:

  • Severe cardiac instability
  • Patients unable to tolerate the procedure due to neurological or cognitive impairment
  • Clinical conditions that would prevent the application of vibration to the chest wall
  • Patients diagnosed with pneumonia
  • Patients with a newly implanted transvenous or subcutaneous pacemaker
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Chest Wall Oscillation Group

    Postoperative patients with chest tubes received manual chest wall vibration in addition to routine nursing care twice daily (morning and evening). Before the intervention, patients were informed and provided written consent. Baseline measurements included dyspnea (Modified Borg Scale), pain (VNRS), vital signs, and arterial blood gas values. The intervention was performed in semi-Fowler's position during the expiratory phase, applying gentle vibrations from lower to upper lobes for approximately 5 minutes (10 breathing cycles). Patients were guided to use slow nasal inhalation and pursed-lip exhalation. Outcomes were reassessed at 3rd, 5th, and 10th minutes after the intervention. The same procedure was repeated in the evening, and all data were recorded.

    Procedure: Chest Wall Oscillation

  • Sham comparator
    Conventional Control Group

    Control group patients were informed about the study and provided written consent. They received only routine nursing care without any additional intervention. At baseline (0 min), Patient Identification and Follow-up Forms were completed. Dyspnea was assessed using the Modified Borg Scale (MBS), pain using the Visual Numeric Rating Scale (VNRS), and vital signs and arterial blood gas values were recorded. Following routine care, measurements of vital signs, blood gases, dyspnea, and pain were repeated at 0, 3, 5, and 10 minutes and documented. Unlike the intervention group, no manual chest wall vibration was applied, and standard clinical follow-up was maintained. The same monitoring and recording procedures were repeated in the evening session.

    Behavioral: Conventional Control

Interventions

  • ProcedureChest Wall Oscillation

    Manual chest wall vibration is applied with the patient in a semi-Fowler's position during the expiratory phase of breathing. The practitioner places both hands flat on the chest wall and delivers gentle, rhythmic vibrations, starting from the lower lobes and progressing toward the upper lobes. Patients are instructed to inhale slowly through the nose and exhale using a pursed-lip breathing technique with a 1:2 inspiration-expiration ratio. The procedure is performed for approximately 5 minutes, corresponding to about 10 respiratory cycles, and is typically applied during the patient's rest period following routine care.

  • BehavioralConventional Control

    Control group patients were informed about the study and provided written consent. They received only routine nursing care, with no additional interventions applied. Baseline measurements were taken at 0 minutes, including dyspnea (MBS), pain (VNRS), vital signs, and arterial blood gas values. Following routine care, the same parameters were reassessed at 3, 5, and 10 minutes and recorded. No manual chest wall vibration was performed; only standard clinical monitoring was maintained. The same assessment protocol was repeated in the evening session.

06

What researchers measure

Primary outcomes

  1. Patient Follow-Up Form

    Changes in respiratory and hemodynamic parameters (including respiratory rate, peripheral oxygen saturation, heart rate, blood pressure), dyspnea severity (Modified Borg Scale), and pain intensity (Visual Numeric Rating Scale) measured before the intervention and at 0, 1, 5, 10, and 15 minutes after the intervention.

    Time frame: 1 day

Secondary outcomes

  1. Post-Operative Respiratory Status Questionnaire

    A 6-item patient-reported questionnaire using a 5-point Likert scale will be used to assess postoperative respiratory symptoms and adherence to breathing exercises. Higher scores indicate better outcomes.

    Time frame: 1 day

  2. Questionnaire on manual chest wall vibration therapy

    A 9-item Likert-type questionnaire will be used to assess patient comfort, perceived benefit, and satisfaction with manual chest wall vibration. Higher scores indicate more favorable outcomes.

    Time frame: 1 day

07

Study locations

1 of 1 sites recruiting
  • Institute of Health Sciences, Saglik Bilimleri University
    Istanbul, Turkey (Türkiye)
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2025 (actual). Primary completion is estimated for Apr 2026, 6 months after the start.

Of 27 interventional studies with no phase under Thoracic Diseases, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 42. This study's planned 6 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 16, 2026
First posted
Apr 24, 2026
StartActual
Oct 1, 2025
Primary completionEst.
Apr 2026
CompletionEst.
May 2026
Last update
Apr 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07549555
Responsible party
Beyza Su (MSc., Nurse, Saglik Bilimleri Universitesi) — Principal investigator
First posted
Apr 24, 2026
Start date
Oct 1, 2025
Primary completion
Apr 2026 (estimated)
Completion
May 2026 (estimated)
Last update
Apr 24, 2026

Study contacts

Beyza SU, MSc.
Contact
beyza.koseoglu.koseoglu@gmail.com
+905347297580
Sibel YİLMAZ SAHİN, Assoc Prof
Contact
sibelyilmaz.sahin@sbu.edu.tr
+905353303222
Sibel YILMAZ SAHİN, Assoc Prof
study director · Institute of Health Sciences, Saglik Bilimleri University
Beyza SU, MSc.
principal investigator · Institute of Health Sciences, Saglik Bilimleri University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion